MSI1 and cancer: Numerous RBPs (e.g. Lin28, IGF2BPs and Musashi-1/2) and DBPs (e.g. NF-κB, c-myc and STAT3) are overexpressed and/or overactivated in human cancers, promoting tumorigenesis and cancer development.